Compare Abeona Therapeutics Inc (ABEO) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Verizon Communications Inc — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while Verizon Communications Inc trades at $46.78 (market cap $196.40B). The key difference: Verizon Communications Inc is far larger — about 466.3× Abeona Therapeutics Inc's market cap, and Verizon Communications Inc pays a 5.99% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | VZ | |
|---|---|---|
Market Cap | $421.19M | $196.40B |
Sector | Health | Media |
52-Week High | $7.45 | $51.38 |
52-Week Low | $4.17 | $38.40 |
Enterprise Value | $276.10M | $383.10B |
Volume | — | 22,584,735 |
Dividend Yield | — | 5.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Verizon (VZ) trades at $47.03, down 0.06% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $49.69. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $1.30 surpassing the $1.27 estimate. The company maintains strong cash flow from operations at $37.14 billion in 2025 and a healthy dividend yield, supported by a $0.71 per share payout scheduled for August 2026.
VZ presents a value opportunity with a low P/E of 12.31 and stable revenue around $138 billion, though competitive pressures from new entrants like SpaceX's Starlink and high debt levels pose risks. Analyst sentiment is mixed with 36.7% buy ratings, but fundamentals suggest resilience for income-focused investors seeking telecom exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
